Nephrotoxicity of Select Rheumatologic Drugs

Tyler Woodell; Rupali S. Avasare

doi:10.1016/j.rdc.2018.06.005

Nephrotoxicity of Select Rheumatologic Drugs

Tyler Woodell
, Rupali S. Avasare

Nephrology and Hypertension

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

Several drugs commonly used in the management of rheumatic diseases may lead to nephrotoxicity, electrolyte disturbances, and hypertension. Here the authors focus on nonsteroidal antiinflammatory drugs, uric-acid-lowering therapy, and commonly used immunosuppressant therapies. The authors include a drug dosing table for patients with kidney disease.

Original language	English (US)
Pages (from-to)	605-617
Number of pages	13
Journal	Rheumatic Disease Clinics of North America
Volume	44
Issue number	4
DOIs	https://doi.org/10.1016/j.rdc.2018.06.005
State	Published - Nov 1 2018

Keywords

Drug dosing in chronic kidney disease
Drug dosing in hemodialysis
Drug-induced electrolyte disorders
Drug-induced nephrotoxicity

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1016/j.rdc.2018.06.005

Cite this

@article{4d4614e2ab7646a5b1882c1efd60762d,

title = "Nephrotoxicity of Select Rheumatologic Drugs",

abstract = "Several drugs commonly used in the management of rheumatic diseases may lead to nephrotoxicity, electrolyte disturbances, and hypertension. Here the authors focus on nonsteroidal antiinflammatory drugs, uric-acid-lowering therapy, and commonly used immunosuppressant therapies. The authors include a drug dosing table for patients with kidney disease.",

keywords = "Drug dosing in chronic kidney disease, Drug dosing in hemodialysis, Drug-induced electrolyte disorders, Drug-induced nephrotoxicity",

author = "Tyler Woodell and Avasare, \{Rupali S.\}",

note = "Publisher Copyright: {\textcopyright} 2018 Elsevier Inc.",

year = "2018",

month = nov,

day = "1",

doi = "10.1016/j.rdc.2018.06.005",

language = "English (US)",

volume = "44",

pages = "605--617",

journal = "Rheumatic Disease Clinics of North America",

issn = "0889-857X",

publisher = "W.B. Saunders",

number = "4",

}

TY - JOUR

T1 - Nephrotoxicity of Select Rheumatologic Drugs

AU - Woodell, Tyler

AU - Avasare, Rupali S.

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Several drugs commonly used in the management of rheumatic diseases may lead to nephrotoxicity, electrolyte disturbances, and hypertension. Here the authors focus on nonsteroidal antiinflammatory drugs, uric-acid-lowering therapy, and commonly used immunosuppressant therapies. The authors include a drug dosing table for patients with kidney disease.

AB - Several drugs commonly used in the management of rheumatic diseases may lead to nephrotoxicity, electrolyte disturbances, and hypertension. Here the authors focus on nonsteroidal antiinflammatory drugs, uric-acid-lowering therapy, and commonly used immunosuppressant therapies. The authors include a drug dosing table for patients with kidney disease.

KW - Drug dosing in chronic kidney disease

KW - Drug dosing in hemodialysis

KW - Drug-induced electrolyte disorders

KW - Drug-induced nephrotoxicity

UR - https://www.scopus.com/pages/publications/85052865759

UR - https://www.scopus.com/pages/publications/85052865759#tab=citedBy

U2 - 10.1016/j.rdc.2018.06.005

DO - 10.1016/j.rdc.2018.06.005

M3 - Review article

C2 - 30274626

AN - SCOPUS:85052865759

SN - 0889-857X

VL - 44

SP - 605

EP - 617

JO - Rheumatic Disease Clinics of North America

JF - Rheumatic Disease Clinics of North America

IS - 4

ER -

Nephrotoxicity of Select Rheumatologic Drugs

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this